Drug intelligence / Profile preview

metoclopramide + dexketoprofen trometamol

Development stage
Unknown
Lead developer
Sanofi
Modality
Small Molecules
Administration
Oral, Intravenous
01

Overview

Metoclopramide + dexketoprofen trometamol is a fixed-dose combination of two active pharmaceutical ingredients used primarily for the acute treatment of migraine and other types of moderate to severe pain. Metoclopramide is a dopamine D2 receptor antagonist with antiemetic and prokinetic properties, commonly used to treat nausea, vomiting, and gastroparesis. Dexketoprofen trometamol is the tromethamine salt form of dexketoprofen, an NSAID (non-steroidal anti-inflammatory drug) that inhibits cyclooxygenase (COX-1 and COX-2), reducing prostaglandin synthesis to provide analgesic, anti-inflammatory, and antipyretic effects. The combination leverages metoclopramide’s ability to control nausea often associated with migraine or pain therapy while enhancing analgesia through dexketoprofen’s action[2][4][6].

02

Targets

HTR4 (5-Hydroxytryptamine receptor 4)PGHS-1 (Prostaglandin G/H Synthase 1)M1 (Muscarinic acetylcholine receptor M1)DRD2 (Dopamine D2 Receptor)HTR3A (5-hydroxytryptamine receptor 3A)

Beyond the preview

Go deeper on metoclopramide + dexketoprofen trometamol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on metoclopramide + dexketoprofen trometamol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call